QUALITY AT EVERY STAGE
As Pakistan undergoes a major demographic transition, the working-age population continues to expand, and the country is uniquely positioned to benefit from the “demographic dividend.” Pakistan’s high dual burden of communicable and non-communicable diseases, however, remains a major threat to the country’s prosperity and well-being.
*IQVIA MAT June 2025
*IQVIA MAT June 2025
For many years after Pakistan’s independence, the pharmaceutical industry remained under the complete dominance of multinational companies. This created the belief that only they were capable of providing quality pharmaceutical products. SAMI challenged this belief and became a pioneer in delivering quality products at prices that respect national resource constraints. We launched quality branded generics, with some occupying leading positions in their respective categories.
SAMI has a firm belief :“Quality in the finished products has to be created from the very start.” We are constantly monitoring and improving the quality of our materials, processes, equipment, and human resources. Our products comply with the high standards required by the authorities, institutions, and, most importantly, by OURSELVES.
Our mission is to defeat the challenge of Pakistan’s communicable and non-communicable diseases by providing products at prices that respect national resource constraints while delivering quality comparable to that of the world’s leading pharmaceutical manufacturers.